Brown Advisory’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$26.3M Buy
303,428
+2,550
+0.8% +$244K 0.04% 283
2025
Q4
$28.9M Sell
300,878
-2,597
-0.9% -$252K 0.04% 271
2025
Q3
$28.9M Buy
303,475
+31,043
+11% +$2.85M 0.04% 275
2025
Q2
$23.7M Sell
272,432
-10,512
-4% -$891K 0.03% 290
2025
Q1
$25.4M Sell
282,944
-842,085
-75% -$75.4M 0.04% 278
2024
Q4
$89.9M Buy
1,125,029
+875,531
+351% +$75.8M 0.11% 141
2024
Q3
$22.5M Sell
249,498
-24,392
-9% -$2.05M 0.03% 321
2024
Q2
$21.6M Sell
273,890
-7,375
-3% -$605K 0.03% 312
2024
Q1
$24.5M Buy
281,265
+6,191
+2% +$528K 0.03% 299
2023
Q4
$22.7M Sell
275,074
-12,920
-4% -$985K 0.03% 308
2023
Q3
$22.6M Buy
287,994
+28,235
+11% +$2.36M 0.04% 297
2023
Q2
$22.9M Sell
259,759
-7,123
-3% -$613K 0.04% 301
2023
Q1
$21.5M Buy
266,882
+52,940
+25% +$4.31M 0.04% 301
2022
Q4
$16.6M Sell
213,942
-11,797
-5% -$956K 0.03% 338
2022
Q3
$18.2M Buy
225,739
+3,313
+1% +$298K 0.04% 313
2022
Q2
$20M Buy
222,426
+11,700
+6% +$1.19M 0.04% 298
2022
Q1
$23.4M Sell
210,726
-4,878
-2% -$515K 0.03% 297
2021
Q4
$22.3M Buy
215,604
+18,259
+9% +$2.11M 0.03% 308
2021
Q3
$24.7M Buy
197,345
+28,564
+17% +$3.7M 0.04% 275
2021
Q2
$21M Buy
168,781
+15,527
+10% +$1.95M 0.03% 289
2021
Q1
$18.1M Sell
153,254
-14,212
-8% -$1.67M 0.03% 283
2020
Q4
$19.6M Buy
167,466
+799
+0.5% +$88K 0.03% 266
2020
Q3
$17.3M Sell
166,667
-2,900
-2% -$291K 0.04% 244
2020
Q2
$15.5M Buy
169,567
+6,844
+4% +$656K 0.04% 251
2020
Q1
$14.7M Sell
162,723
-2,332
-1% -$248K 0.05% 236
2019
Q4
$18.7M Buy
165,055
+5,969
+4% +$655K 0.05% 257
2019
Q3
$17.3M Buy
159,086
+3,878
+2% +$405K 0.05% 255
2019
Q2
$15.1M Sell
155,208
-55,043
-26% -$5.03M 0.04% 273
2019
Q1
$19.1M Buy
210,251
+34,137
+19% +$3.06M 0.05% 253
2018
Q4
$16M Buy
176,114
+5,181
+3% +$484K 0.05% 265
2018
Q3
$16.8M Sell
170,933
-10,614
-6% -$981K 0.05% 272
2018
Q2
$15.5M Buy
181,547
+54,654
+43% +$4.57M 0.05% 265
2018
Q1
$10.2M Sell
126,893
-29,538
-19% -$2.44M 0.03% 302
2017
Q4
$12.6M Buy
156,431
+92,171
+143% +$7.38M 0.04% 283
2017
Q3
$5M Sell
64,260
-36,572
-36% -$3.04M 0.02% 398
2017
Q2
$8.95M Buy
100,832
+29,000
+40% +$2.45M 0.03% 332
2017
Q1
$5.79M Sell
71,832
-4,493
-6% -$351K 0.02% 353
2016
Q4
$5.44M Sell
76,325
-17,528
-19% -$1.38M 0.02% 359
2016
Q3
$8.11M Sell
93,853
-349
-0.4% -$30.4K 0.03% 307
2016
Q2
$8.17M Buy
94,202
+2,064
+2% +$167K 0.03% 303
2016
Q1
$6.91M Buy
92,138
+16,879
+22% +$1.27M 0.02% 320
2015
Q4
$5.79M Sell
75,259
-9,820
-12% -$739K 0.02% 345
2015
Q3
$5.7M Sell
85,079
-13,130
-13% -$967K 0.02% 339
2015
Q2
$7.28M Buy
98,209
+3,097
+3% +$237K 0.02% 305
2015
Q1
$7.42M Buy
+95,112
New +$7.21M 0.02% 309
2014
Q4
Sell
-74,658
Closed -$4.63M 952
2014
Q3
$4.63M Buy
74,658
+2,442
+3% +$155K 0.01% 346
2014
Q2
$4.6M Sell
72,216
-53
-0.1% -$3.22K 0.01% 341
2014
Q1
$4.45M Sell
72,269
-12,562
-15% -$732K 0.01% 341
2013
Q4
$4.87M Buy
84,831
+2,065
+2% +$117K 0.02% 324
2013
Q3
$4.41M Buy
82,766
+12,570
+18% +$676K 0.02% 328
2013
Q2
$3.61M Buy
+70,196
New +$3.47M 0.01% 333

Other funds holding MDT

Brown Advisory's MDT Position: Q1 2026 in Review

Brown Advisory increased its Medtronic (MDT) stake by 0.85% in Q1 2026, buying an estimated $244K and bringing the position to 303,428 shares worth $26.3M. The position accounts for 0.04% of the portfolio, ranked #283.

Brown Advisory first reported a position in MDT in Q2 2013 and has held it in 51 quarters since. The position peaked at $89.9M in Q4 2024. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Brown Advisory held 303,428 shares of Medtronic worth $26.3M as of Q1 2026.
  • Brown Advisory bought 2,550 Medtronic shares in Q1 2026, an estimated $244K.
  • Medtronic made up 0.04% of Brown Advisory's portfolio in Q1 2026, its #283 holding.
  • Brown Advisory first reported a position in Medtronic in Q2 2013 and has held it in 51 quarters since.
  • Brown Advisory's Medtronic position peaked at $89.9M in Q4 2024.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Brown Advisory's 13F filing for Q1 2026, filed 15 May 2026.